(CTVA) Corteva - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US22052L1044
CTVA: Seeds, Herbicides, Insecticides, Fertilizers, Pest Control, Digital
Corteva, Inc. (NYSE:CTVA) is a global leader in agricultural solutions, operating through two core segments: Seed and Crop Protection. The Seed segment specializes in developing high-performance germplasm and traits designed to maximize yield and resilience. It offers advanced technologies that enhance resistance to environmental stressors, diseases, insects, and herbicides, while also improving nutritional quality. Additionally, this segment provides precision agriculture tools that leverage data analytics to optimize planting decisions, yield potential, and profitability. The Crop Protection segment delivers a comprehensive portfolio of solutions to safeguard crops from weeds, insects, pests, and diseases. It also focuses on enhancing soil and plant health through innovations in nitrogen management and seed-applied technologies. Key offerings include herbicides, insecticides, fungicides, and pasture management solutions. Corteva serves the agricultural input industry worldwide, with operations spanning the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa. Headquartered in Indianapolis, Indiana, the company was established in 2018 as an independent entity following its separation from DowDuPont. Web URL: https://www.corteva.com.
As of the latest data, Corteva, Inc. is categorized under the Fertilizers & Agricultural Chemicals sub-industry, listed on the NYSE under the ticker symbol CTVA. The companys current market capitalization stands at $38,105.41 million USD, with a price-to-earnings (P/E) ratio of 45.73 and a forward P/E of 19.16. Its price-to-book (P/B) ratio is 1.60, and the price-to-sales (P/S) ratio is 2.25. The return on equity (RoE) is reported at 3.81%. Technically, the stocks average 20-day volume is 3,097,035 shares, with a last price of $59.74. Key moving averages include the SMA 20 at $60.26, SMA 50 at $61.16, and SMA 200 at $58.28. The average true range (ATR) is 1.86.
3-Month Forecast (Based on Technical and Fundamental Data): - Technical Outlook: The stock is currently trading near its 20-day SMA ($60.26), indicating potential resistance. The SMA 50 ($61.16) and SMA 200 ($58.28) suggest a narrowing range, with the stock oscillating around these levels. A break above $61.16 could signal upward momentum, while a drop below $58.28 may indicate a downtrend. The ATR of 1.86 suggests moderate volatility. - Fundamental Outlook: With a forward P/E of 19.16, the stock is priced at a premium, reflecting expectations of future growth. The P/S ratio of 2.25 aligns with industry averages, indicating reasonable valuation relative to sales. A Market Cap of $38,105.41M underscores Cortevas market leadership in the agricultural chemicals sector. The RoE of 3.81% suggests modest profitability, but the companys focus on innovation and global distribution could drive future returns.Additional Sources for CTVA Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CTVA Stock Overview
Market Cap in USD | 40,803m |
Sector | Basic Materials |
Industry | Agricultural Inputs |
GiC Sub-Industry | Fertilizers & Agricultural Chemicals |
IPO / Inception | 2019-05-24 |
CTVA Stock Ratings
Growth Rating | 77.5 |
Fundamental | 17.9 |
Dividend Rating | 57.7 |
Rel. Strength | 19.3 |
Analysts | 4.26/5 |
Fair Price Momentum | 61.59 USD |
Fair Price DCF | 90.46 USD |
CTVA Dividends
Dividend Yield 12m | 1.14% |
Yield on Cost 5y | 2.71% |
Annual Growth 5y | 4.88% |
Payout Consistency | 100.0% |
CTVA Growth Ratios
Growth Correlation 3m | -71.6% |
Growth Correlation 12m | 78.1% |
Growth Correlation 5y | 73.3% |
CAGR 5y | 19.69% |
CAGR/Max DD 5y | 0.57 |
Sharpe Ratio 12m | -0.32 |
Alpha | 4.86 |
Beta | 0.780 |
Volatility | 26.44% |
Current Volume | 1652.2k |
Average Volume 20d | 3097k |
As of April 23, 2025, the stock is trading at USD 60.65 with a total of 1,652,198 shares traded.
Over the past week, the price has changed by +1.59%, over one month by -2.29%, over three months by -2.71% and over the past year by +11.13%.
Neither. Based on ValueRay Fundamental Analyses, Corteva is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 17.86 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CTVA as of April 2025 is 61.59. This means that CTVA is currently overvalued and has a potential downside of 1.55%.
Corteva has received a consensus analysts rating of 4.26. Therefor, it is recommend to buy CTVA.
- Strong Buy: 12
- Buy: 5
- Hold: 6
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, CTVA Corteva will be worth about 67.6 in April 2026. The stock is currently trading at 60.65. This means that the stock has a potential upside of +11.53%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 69.1 | 13.9% |
Analysts Target Price | 66.4 | 9.4% |
ValueRay Target Price | 67.6 | 11.5% |